4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000903423-16-001314
Options or other derivatives
- 10% owner acquired 30,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| GLAXOSMITHKLINE PLC 10% owner | 2016-10-18 | Grant or award · Stock Option | +30,000 | 30,000 | I | ||
Loading xslF345X03/glaxo-crispr.xml…